Concepedia

Aaron Miller

AM

Statistics

Publications

60

Citations

5.5K

H-Index

32

Active since

1957

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of Ottawa

Ottawa Hospital

Sanofi (France)

The University of Texas Health Science Center at Houston

Aaron Miller is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, multiple sclerosis, and neurology.

ORCID

Top concepts

Publications per year

1957–2024

60

Publications

60

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Christian Confavreux, Paul O’Connor, Mark Freedman et al. · The Lancet Neurology · 2014 · 566 citations

, , +6

A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis

Murray B. Bornstein, Aaron Miller, Susan Slagle et al. · New England Journal of Medicine · 1987 · 463 citations

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani, Thomas A. D’Amico, David J. Bentrem et al. · Journal of the National Comprehensive Cancer Network · 2023 · 450 citations · Full text

, , +17

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial

Jerry S. Wolinsky, Ponnada A. Narayana, Paul O’Connor et al. · Annals of Neurology · 2007 · 423 citations · Full text

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial

Patrick Vermersch, Anna Członkowska, Luigi ME Grimaldi et al. · Multiple Sclerosis Journal · 2013 · 348 citations · Full text

1–5 of 60